Your browser doesn't support javascript.
loading
Repurposing sodium-glucose co-transporter 2 inhibitors (SGLT2i) for cancer treatment - A Review.
Lau, Kristy T K; Ng, Lui; Wong, Jason W H; Loong, Herbert H F; Chan, Wendy W L; Lee, Chi Ho; Wong, Carlos K H.
Afiliação
  • Lau KTK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Ng L; Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Wong JWH; School of Biomedical Sciences, Faculty of Medicine, Li Ka Shing, The University of Hong Kong, Hong Kong SAR, China.
  • Loong HHF; Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Chan WWL; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Lee CH; Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Wong CKH; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. carlosho@hku.hk.
Rev Endocr Metab Disord ; 22(4): 1121-1136, 2021 12.
Article em En | MEDLINE | ID: mdl-34272645

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simportadores / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Rev Endocr Metab Disord Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simportadores / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Rev Endocr Metab Disord Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha